In a study on 870 breast cancer patients, Qin et al.48found that the disease‐free survival (DFS), metastasis‐free survival (MFS), and OS of patients with high PD‐L1 expression were all lower when compared with patients with negative expression of PD‐L1. Here, CD274 is linked to breast carcinoma.